Details for: SPAST
Gene ID: 6683
Gene Type: Protein-coding - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.
Symbol: SPAST
Ensembl ID: ENSG00000021574
Description: spastin
Selected Context(s): Overall
Cell Significance Landscape
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 8.93rCSI 23.71%PRS 72.83
-
CSI 8.35rCSI 14.01%PRS 43.08
-
CSI 7.97rCSI 16.96%PRS 60.61
-
CSI 6.08rCSI 21.86%PRS 41.48
-
CSI 5.72rCSI 17.86%PRS 44.7
-
CSI 4.93rCSI 12.84%PRS 61.14
-
CSI 4.67rCSI 26.9%PRS 59.95
-
CSI 4.09rCSI 16.49%PRS 60.16
-
CSI 4.07rCSI 9.28%PRS 53.11
-
CSI 3.91rCSI 5.44%PRS 59.88
-
CSI 3.47rCSI 2.98%PRS 69.56
-
CSI 3.46rCSI 5.51%PRS 53.92
-
CSI 3.34rCSI 2.6%PRS 79.15
-
CSI 3.23rCSI 2.84%PRS 49.11
-
CSI 3.01rCSI 7.36%PRS 54.92
-
CSI 3rCSI 4.82%PRS 50.83
-
CSI 2.95rCSI 17.37%PRS 44.37
-
CSI 2.9rCSI 2.34%PRS 62.72
-
CSI 2.83rCSI 2.1%PRS 53.88
-
CSI 2.8rCSI 9.38%PRS 46.49
-
CSI 2.65rCSI 4.26%PRS 45.13
-
CSI 2.64rCSI 5.84%PRS 59.19
-
CSI 2.62rCSI 8.21%PRS 47.23
-
CSI 2.61rCSI 3.71%PRS 57.54
-
CSI 2.56rCSI 4.8%PRS 49.63
-
CSI 2.56rCSI 4.07%PRS 53.63
-
CSI 2.53rCSI 2.04%PRS 71.91
-
CSI 2.53rCSI 7.18%PRS 59.52
-
CSI 2.52rCSI 5.11%PRS 40.78
-
CSI 2.47rCSI 1.73%PRS 79.55
-
CSI 2.46rCSI 4.93%PRS 50.31
-
CSI 2.44rCSI 2.53%PRS 66.87
-
CSI 2.41rCSI 5.48%PRS 65.34
-
CSI 2.35rCSI 9.57%PRS 55.76
-
CSI 2.33rCSI 2.9%PRS 63.05
-
CSI 2.3rCSI 5.27%PRS 61.16
-
CSI 2.25rCSI 3.6%PRS 65.59
-
CSI 2.23rCSI 2.78%PRS 41.13
-
CSI 2.19rCSI 3.87%PRS 42.12
-
CSI 2.17rCSI 6.41%PRS 64.43
-
CSI 2.13rCSI 1.44%PRS 74.43
-
CSI 2.12rCSI 8.02%PRS 43.87
-
CSI 2.12rCSI 2.18%PRS 77.79
-
CSI 2.11rCSI 2.71%PRS 58.41
-
CSI 2.1rCSI 3.09%PRS 54.9
-
CSI 2.09rCSI 7.84%PRS 53.41
-
CSI 2.08rCSI 9.98%PRS 61.44
-
CSI 2.06rCSI 6.58%PRS 58.61
-
CSI 2.04rCSI 1.69%PRS 63.47
-
CSI 2.03rCSI 3.1%PRS 70.77
-
CSI 2.02rCSI 4.82%PRS 62.33
-
CSI 1.98rCSI 2.36%PRS 42.85
-
CSI 1.94rCSI 1.83%PRS 60.79
-
CSI 1.93rCSI 1.46%PRS 75.19
-
CSI 1.93rCSI 4%PRS 58.56
-
CSI 1.93rCSI 2.4%PRS 72.16
-
CSI 1.9rCSI 4.24%PRS 69.08
-
CSI 1.89rCSI 3.1%PRS 50.57
-
CSI 1.89rCSI 2.18%PRS 54.43
-
CSI 1.88rCSI 4.87%PRS 56.24
-
CSI 1.88rCSI 2.56%PRS 53.01
-
CSI 1.88rCSI 3.29%PRS 53.26
-
CSI 1.87rCSI 4.82%PRS 61.02
-
CSI 1.85rCSI 3.2%PRS 51.5
-
CSI 1.85rCSI 4.49%PRS 41.67
-
CSI 1.83rCSI 4.23%PRS 50.4
-
CSI 1.79rCSI 1.62%PRS 58.08
-
CSI 1.79rCSI 2.45%PRS 54.93
-
CSI 1.79rCSI 6.74%PRS 48.03
-
CSI 1.76rCSI 1.39%PRS 48.1
-
CSI 1.69rCSI 3.03%PRS 54.32
-
CSI 1.68rCSI 1.62%PRS 51.87
-
CSI 1.67rCSI 3.74%PRS 43.8
-
CSI 1.65rCSI 39.49%PRS 42.12
-
CSI 1.63rCSI 2.34%PRS 51.02
-
CSI 1.61rCSI 38.79%PRS 43.05
-
CSI 1.6rCSI 3.3%PRS 51.69
-
CSI 1.58rCSI 4.22%PRS 52.38
-
CSI 1.57rCSI 2.86%PRS 53.21
-
CSI 1.56rCSI 2.38%PRS 61.9
-
CSI 1.52rCSI 3.94%PRS 64.78
-
CSI 1.5rCSI 1.82%PRS 70.25
-
CSI 1.49rCSI 3.69%PRS 59.68
-
CSI 1.48rCSI 3.75%PRS 50.73
-
CSI 1.46rCSI 2.4%PRS 66.6
-
CSI 1.42rCSI 8.05%PRS 46.33
-
CSI 1.39rCSI 1.8%PRS 44.34
-
CSI 1.38rCSI 11.85%PRS 48.67
-
CSI 1.26rCSI 0.97%PRS 61.74
-
CSI 1.23rCSI 1.52%PRS 57.79
-
CSI 1.23rCSI 2.93%PRS 48.58
-
CSI 1.21rCSI 1.85%PRS 65.53
-
CSI 1.21rCSI 5.39%PRS 45.35
-
CSI 1.17rCSI 8.62%PRS 48.05
-
CSI 1.09rCSI 1%PRS 75.96
-
CSI 1.02rCSI 2.46%PRS 79.02
-
CSI 0.95rCSI 0.82%PRS 66.28
-
CSI 0.92rCSI 1.4%PRS 65.48
-
CSI 0.85rCSI 1.88%PRS 47.47
-
CSI 0.84rCSI 5.55%PRS 58.55
-
CSI 0.4rCSI 6.2%PRS 66.4%
-
CSI 0.4rCSI 8.2%PRS 53.5%
-
CSI 0.4rCSI 5.9%PRS 52.5%
-
CSI 0.6rCSI 3.8%PRS 57.1%
-
CSI 0.6rCSI 3.1%PRS 58.8%
-
CSI 0.7rCSI 13.6%PRS 52.2%
-
CSI 0.7rCSI 2.2%PRS 48.2%
-
CSI 0.7rCSI 2.5%PRS 50.2%
-
CSI 0.8rCSI 3.4%PRS 51.7%
-
CSI 0.8rCSI 6.3%PRS 54.6%
-
CSI 0.8rCSI 3.0%PRS 52.2%
-
CSI 0.8rCSI 5.1%PRS 53.2%
-
CSI 0.8rCSI 2.4%PRS 51.0%
-
CSI 0.8rCSI 5.6%PRS 58.6%
-
CSI 0.9rCSI 1.9%PRS 47.5%
-
CSI 0.9rCSI 1.4%PRS 65.5%
-
CSI 1.0rCSI 0.8%PRS 66.3%
-
CSI 1.0rCSI 2.5%PRS 79.0%
-
CSI 1.1rCSI 1.0%PRS 76.0%
-
CSI 1.2rCSI 8.6%PRS 48.1%
-
CSI 1.2rCSI 5.4%PRS 45.4%
-
CSI 1.2rCSI 1.9%PRS 65.5%
-
CSI 1.2rCSI 2.9%PRS 48.6%
-
CSI 1.2rCSI 1.5%PRS 57.8%
-
CSI 1.3rCSI 1.0%PRS 61.7%
-
CSI 1.4rCSI 11.9%PRS 48.7%
-
CSI 1.4rCSI 1.8%PRS 44.3%
-
CSI 1.4rCSI 8.1%PRS 46.3%
-
CSI 1.5rCSI 2.4%PRS 66.6%
-
CSI 1.5rCSI 3.8%PRS 50.7%
-
CSI 1.5rCSI 3.7%PRS 59.7%
-
CSI 1.5rCSI 1.8%PRS 70.3%
-
CSI 1.5rCSI 3.9%PRS 64.8%
-
CSI 1.6rCSI 2.4%PRS 61.9%
-
CSI 1.6rCSI 2.9%PRS 53.2%
-
CSI 1.6rCSI 4.2%PRS 52.4%
-
CSI 1.6rCSI 3.3%PRS 51.7%
-
CSI 1.6rCSI 38.8%PRS 43.1%
-
CSI 1.6rCSI 2.3%PRS 51.0%
-
CSI 1.7rCSI 39.5%PRS 42.1%
-
CSI 1.7rCSI 3.7%PRS 43.8%
-
CSI 1.7rCSI 1.6%PRS 51.9%
-
CSI 1.7rCSI 3.0%PRS 54.3%
-
CSI 1.8rCSI 1.4%PRS 48.1%
-
CSI 1.8rCSI 6.7%PRS 48.0%
-
CSI 1.8rCSI 2.5%PRS 54.9%
-
CSI 1.8rCSI 1.6%PRS 58.1%
-
CSI 1.8rCSI 4.2%PRS 50.4%
-
CSI 1.9rCSI 4.5%PRS 41.7%
-
CSI 1.9rCSI 3.2%PRS 51.5%
-
CSI 1.9rCSI 4.8%PRS 61.0%
-
CSI 1.9rCSI 3.3%PRS 53.3%
-
CSI 1.9rCSI 2.6%PRS 53.0%
-
CSI 1.9rCSI 4.9%PRS 56.2%
-
CSI 1.9rCSI 2.2%PRS 54.4%
-
CSI 1.9rCSI 3.1%PRS 50.6%
-
CSI 1.9rCSI 4.2%PRS 69.1%
-
CSI 1.9rCSI 2.4%PRS 72.2%
-
CSI 1.9rCSI 4.0%PRS 58.6%
-
CSI 1.9rCSI 1.5%PRS 75.2%
-
CSI 1.9rCSI 1.8%PRS 60.8%
-
CSI 2.0rCSI 2.4%PRS 42.9%
-
CSI 2.0rCSI 4.8%PRS 62.3%
-
CSI 2.0rCSI 3.1%PRS 70.8%
-
CSI 2.0rCSI 1.7%PRS 63.5%
-
CSI 2.1rCSI 6.6%PRS 58.6%
-
CSI 2.1rCSI 10.0%PRS 61.4%
-
CSI 2.1rCSI 7.8%PRS 53.4%
-
CSI 2.1rCSI 3.1%PRS 54.9%
-
CSI 2.1rCSI 2.7%PRS 58.4%
-
CSI 2.1rCSI 2.2%PRS 77.8%
-
CSI 2.1rCSI 8.0%PRS 43.9%
-
CSI 2.1rCSI 1.4%PRS 74.4%
-
CSI 2.2rCSI 6.4%PRS 64.4%
-
CSI 2.2rCSI 3.9%PRS 42.1%
-
CSI 2.2rCSI 2.8%PRS 41.1%
-
CSI 2.3rCSI 3.6%PRS 65.6%
-
CSI 2.3rCSI 5.3%PRS 61.2%
-
CSI 2.3rCSI 2.9%PRS 63.1%
-
CSI 2.4rCSI 9.6%PRS 55.8%
-
CSI 2.4rCSI 5.5%PRS 65.3%
-
CSI 2.4rCSI 2.5%PRS 66.9%
-
CSI 2.5rCSI 4.9%PRS 50.3%
-
CSI 2.5rCSI 1.7%PRS 79.6%
-
CSI 2.5rCSI 5.1%PRS 40.8%
-
CSI 2.5rCSI 7.2%PRS 59.5%
-
CSI 2.5rCSI 2.0%PRS 71.9%
-
CSI 2.6rCSI 4.1%PRS 53.6%
-
CSI 2.6rCSI 4.8%PRS 49.6%
-
CSI 2.6rCSI 3.7%PRS 57.5%
-
CSI 2.6rCSI 8.2%PRS 47.2%
-
CSI 2.6rCSI 5.8%PRS 59.2%
-
CSI 2.7rCSI 4.3%PRS 45.1%
-
CSI 2.8rCSI 9.4%PRS 46.5%
-
CSI 2.8rCSI 2.1%PRS 53.9%
-
CSI 2.9rCSI 2.3%PRS 62.7%
-
CSI 3.0rCSI 17.4%PRS 44.4%
-
CSI 3.0rCSI 4.8%PRS 50.8%
-
CSI 3.0rCSI 7.4%PRS 54.9%
-
CSI 3.2rCSI 2.8%PRS 49.1%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 840893059
Symbol: SPAST_HUMAN
Name: Spastic paraplegia 4 protein
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 10610178
Title: Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia.
PubMed ID: 10610178
DOI: 10.1038/15472
PubMed ID: 10470851
Title: Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.
PubMed ID: 10470851
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 11809724
Title: Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics.
PubMed ID: 11809724
DOI: 10.1093/hmg/11.2.153
PubMed ID: 12676568
Title: The identification of a conserved domain in both spartin and spastin, mutated in hereditary spastic paraplegia.
PubMed ID: 12676568
PubMed ID: 15147984
Title: Identification of nuclear localisation sequences in spastin (SPG4) using a novel Tetra-GFP reporter system.
PubMed ID: 15147984
PubMed ID: 15269182
Title: Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody and the distal axon.
PubMed ID: 15269182
DOI: 10.1093/hmg/ddh223
PubMed ID: 16026783
Title: Spastin subcellular localization is regulated through usage of different translation start sites and active export from the nucleus.
PubMed ID: 16026783
PubMed ID: 15537668
Title: The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B.
PubMed ID: 15537668
DOI: 10.1093/hmg/ddi003
PubMed ID: 15716377
Title: Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing.
PubMed ID: 15716377
PubMed ID: 16219033
Title: Human spastin has multiple microtubule-related functions.
PubMed ID: 16219033
PubMed ID: 15891913
Title: Subcellular localization of spastin: implications for the pathogenesis of hereditary spastic paraplegia.
PubMed ID: 15891913
PubMed ID: 16826525
Title: ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia.
PubMed ID: 16826525
DOI: 10.1086/504927
PubMed ID: 16339213
Title: Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners.
PubMed ID: 16339213
DOI: 10.1093/hmg/ddi447
PubMed ID: 16602018
Title: Spastin, the most commonly mutated protein in hereditary spastic paraplegia interacts with Reticulon 1 an endoplasmic reticulum protein.
PubMed ID: 16602018
PubMed ID: 16815977
Title: Interaction of two hereditary spastic paraplegia gene products, spastin and atlastin, suggests a common pathway for axonal maintenance.
PubMed ID: 16815977
PubMed ID: 17389232
Title: Recognition of C-terminal amino acids in tubulin by pore loops in Spastin is important for microtubule severing.
PubMed ID: 17389232
PubMed ID: 18613979
Title: A cryptic promoter in the first exon of the SPG4 gene directs the synthesis of the 60-kDa spastin isoform.
PubMed ID: 18613979
PubMed ID: 18410514
Title: Spastin oligomerizes into a hexamer and the mutant spastin (E442Q) redistribute the wild-type spastin into filamentous microtubule.
PubMed ID: 18410514
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19690332
Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
PubMed ID: 19690332
PubMed ID: 19000169
Title: Spastin couples microtubule severing to membrane traffic in completion of cytokinesis and secretion.
PubMed ID: 19000169
PubMed ID: 20200447
Title: Hereditary spastic paraplegia proteins REEP1, spastin, and atlastin-1 coordinate microtubule interactions with the tubular ER network.
PubMed ID: 20200447
DOI: 10.1172/jci40979
PubMed ID: 20530212
Title: Tubulin polyglutamylation stimulates spastin-mediated microtubule severing.
PubMed ID: 20530212
PubMed ID: 20068231
Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
PubMed ID: 20068231
PubMed ID: 21406692
Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
PubMed ID: 21406692
PubMed ID: 21310966
Title: Cortical constriction during abscission involves helices of ESCRT-III-dependent filaments.
PubMed ID: 21310966
PubMed ID: 22637577
Title: Subunit Interactions and cooperativity in the microtubule-severing AAA ATPase spastin.
PubMed ID: 22637577
PubMed ID: 22232211
Title: Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12.
PubMed ID: 22232211
DOI: 10.1172/jci60560
PubMed ID: 23272056
Title: Spastin's microtubule-binding properties and comparison to katanin.
PubMed ID: 23272056
PubMed ID: 23745751
Title: The nucleotide cycle of spastin correlates with its microtubule-binding properties.
PubMed ID: 23745751
DOI: 10.1111/febs.12385
PubMed ID: 23897888
Title: An ESCRT-spastin interaction promotes fission of recycling tubules from the endosome.
PubMed ID: 23897888
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 23969831
Title: Protrudin binds atlastins and endoplasmic reticulum-shaping proteins and regulates network formation.
PubMed ID: 23969831
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
PubMed ID: 25390646
Title: Spastin-interacting protein NA14/SSNA1 functions in cytokinesis and axon development.
PubMed ID: 25390646
PubMed ID: 26040712
Title: Spastin and ESCRT-III coordinate mitotic spindle disassembly and nuclear envelope sealing.
PubMed ID: 26040712
DOI: 10.1038/nature14408
PubMed ID: 25875445
Title: Spastin binds to lipid droplets and affects lipid metabolism.
PubMed ID: 25875445
PubMed ID: 26875866
Title: Graded control of microtubule severing by tubulin glutamylation.
PubMed ID: 26875866
PubMed ID: 18997780
Title: Structural basis for midbody targeting of spastin by the ESCRT-III protein CHMP1B.
PubMed ID: 18997780
DOI: 10.1038/nsmb.1512
PubMed ID: 22446388
Title: Crystal structure of the human spastin AAA domain.
PubMed ID: 22446388
PubMed ID: 11039577
Title: Hereditary spastic paraplegia caused by mutations in the SPG4 gene.
PubMed ID: 11039577
PubMed ID: 10699187
Title: Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia.
PubMed ID: 10699187
DOI: 10.1093/hmg/9.4.637
PubMed ID: 11015453
Title: Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis.
PubMed ID: 11015453
PubMed ID: 11087788
Title: Novel mutations in spastin gene and absence of correlation with age at onset of symptoms.
PubMed ID: 11087788
PubMed ID: 11309678
Title: Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia.
PubMed ID: 11309678
DOI: 10.1086/320111
PubMed ID: 12460147
Title: A Japanese SPG4 family with a novel missense mutation of the SPG4 gene: intrafamilial variability in age at onset and clinical severity.
PubMed ID: 12460147
PubMed ID: 11843700
Title: Spectrum of SPG4 mutations in a large collection of North American families with hereditary spastic paraplegia.
PubMed ID: 11843700
PubMed ID: 12124993
Title: Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia.
PubMed ID: 12124993
DOI: 10.1002/humu.10105
PubMed ID: 12161613
Title: Spastin gene mutation in Japanese with hereditary spastic paraplegia.
PubMed ID: 12161613
DOI: 10.1136/jmg.39.8.e46
PubMed ID: 11985387
Title: Missense and splice site mutations in SPG4 suggest loss-of-function in dominant spastic paraplegia.
PubMed ID: 11985387
DOI: 10.1007/pl00007865
PubMed ID: 12163196
Title: Three novel spastin (SPG4) mutations in families with autosomal dominant hereditary spastic paraplegia.
PubMed ID: 12163196
PubMed ID: 12202986
Title: A novel missense mutation (I344K) in the SPG4gene in a Korean family with autosomal-dominant hereditary spastic paraplegia.
PubMed ID: 12202986
PubMed ID: 12552568
Title: Screening of patients with hereditary spastic paraplegia reveals seven novel mutations in the SPG4 (Spastin) gene.
PubMed ID: 12552568
DOI: 10.1002/humu.9108
PubMed ID: 12939659
Title: Novel spastin mutations and their expression analysis in two Italian families.
PubMed ID: 12939659
PubMed ID: 14732620
Title: Three novel mutations of the spastin gene in Chinese patients with hereditary spastic paraplegia.
PubMed ID: 14732620
PubMed ID: 15210521
Title: Hereditary spastic paraplegia: clinical genetic study of 15 families.
PubMed ID: 15210521
PubMed ID: 15667412
Title: Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation.
PubMed ID: 15667412
PubMed ID: 15248095
Title: Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations.
PubMed ID: 15248095
PubMed ID: 15482961
Title: Two novel mutations in the spastin gene (SPG4) found by DHPLC mutation analysis.
PubMed ID: 15482961
PubMed ID: 15159500
Title: A new SPG4 mutation in a variant form of spastic paraplegia with congenital arachnoid cysts.
PubMed ID: 15159500
PubMed ID: 15326248
Title: Infantile hereditary spastic paraparesis due to codominant mutations in the spastin gene.
PubMed ID: 15326248
PubMed ID: 16682546
Title: Eight novel mutations in SPG4 in a large sample of patients with hereditary spastic paraplegia.
PubMed ID: 16682546
PubMed ID: 16684598
Title: Novel spastin (SPG4) mutations in Italian patients with hereditary spastic paraplegia.
PubMed ID: 16684598
PubMed ID: 16959974
Title: The consensus coding sequences of human breast and colorectal cancers.
PubMed ID: 16959974
PubMed ID: 17594340
Title: Seven novel mutations and four exon deletions in a collection of Norwegian patients with SPG4 hereditary spastic paraplegia.
PubMed ID: 17594340
PubMed ID: 20214791
Title: Unique spectrum of SPAST variants in Estonian HSP patients: presence of benign missense changes but lack of exonic rearrangements.
PubMed ID: 20214791
PubMed ID: 20932283
Title: Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia.
PubMed ID: 20932283
PubMed ID: 20562464
Title: Hereditary spastic paraplegia due to SPAST mutations in 151 Dutch patients: new clinical aspects and 27 novel mutations.
PubMed ID: 20562464
PubMed ID: 20718791
Title: Mutation screening of spastin, atlastin, and REEP1 in hereditary spastic paraplegia.
PubMed ID: 20718791
PubMed ID: 20550563
Title: Clinical and genetic findings in a series of Italian children with pure hereditary spastic paraplegia.
PubMed ID: 20550563
PubMed ID: 21546041
Title: Detection of novel mutations and review of published data suggests that hereditary spastic paraplegia caused by spastin (SPAST) mutations is found more often in males.
PubMed ID: 21546041
PubMed ID: 22960362
Title: Novel and recurrent spastin mutations in a large series of SPG4 Italian families.
PubMed ID: 22960362
PubMed ID: 23279441
Title: First mutation in the nuclear localization signal sequence of spastin protein identified in a patient with hereditary spastic paraplegia.
PubMed ID: 23279441
DOI: 10.1111/ene.12000
PubMed ID: 25421405
Title: High frequency of SPG4 in Taiwanese families with autosomal dominant hereditary spastic paraplegia.
PubMed ID: 25421405
PubMed ID: 25045380
Title: Mutation analysis of SPAST, ATL1, and REEP1 in Korean Patients with Hereditary Spastic Paraplegia.
PubMed ID: 25045380
PubMed ID: 24824479
Title: Spastin mutation screening in Chinese patients with pure hereditary spastic paraplegia.
PubMed ID: 24824479
PubMed ID: 28572275
Title: Truncating mutations in SPAST patients are associated with a high rate of psychiatric comorbidities in hereditary spastic paraplegia.
PubMed ID: 28572275
Sequence Information:
- Length: 616
- Mass: 67197
- Checksum: 75E5FC5787132B4C
- Sequence:
MNSPGGRGKK KGSGGASNPV PPRPPPPCLA PAPPAAGPAP PPESPHKRNL YYFSYPLFVG FALLRLVAFH LGLLFVWLCQ RFSRALMAAK RSSGAAPAPA SASAPAPVPG GEAERVRVFH KQAFEYISIA LRIDEDEKAG QKEQAVEWYK KGIEELEKGI AVIVTGQGEQ CERARRLQAK MMTNLVMAKD RLQLLEKMQP VLPFSKSQTD VYNDSTNLAC RNGHLQSESG AVPKRKDPLT HTSNSLPRSK TVMKTGSAGL SGHHRAPSYS GLSMVSGVKQ GSGPAPTTHK GTPKTNRTNK PSTPTTATRK KKDLKNFRNV DSNLANLIMN EIVDNGTAVK FDDIAGQDLA KQALQEIVIL PSLRPELFTG LRAPARGLLL FGPPGNGKTM LAKAVAAESN ATFFNISAAS LTSKYVGEGE KLVRALFAVA RELQPSIIFI DEVDSLLCER REGEHDASRR LKTEFLIEFD GVQSAGDDRV LVMGATNRPQ ELDEAVLRRF IKRVYVSLPN EETRLLLLKN LLCKQGSPLT QKELAQLARM TDGYSGSDLT ALAKDAALGP IRELKPEQVK NMSASEMRNI RLSDFTESLK KIKRSVSPQT LEAYIRWNKD FGDTTV
Genular Protein ID: 2143725779
Symbol: E5KRP6_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 20843780
Title: Identification of rare DNA variants in mitochondrial disorders with improved array-based sequencing.
PubMed ID: 20843780
DOI: 10.1093/nar/gkq750
Sequence Information:
- Length: 584
- Mass: 63606
- Checksum: 502F0FCB78ECED14
- Sequence:
MNSPGGRGKK KGSGGASNPV PPRPPPPCLA PAPPAAGPAP PPESPHKRNL YYFSYPLFVG FALLRLVAFH LGLLFVWLCQ RFSRALMAAK RSSGAAPAPA SASAPAPVPG GEAERVRVFH KQAFEYISIA LRIDEDEKAG QKEQAVEWYK KGIEELEKGI AVIVTGQGEQ CERARRLQAK MMTNLVMAKD RLQLLESGAV PKRKDPLTHT SNSLPRSKTV MKTGSAGLSG HHRAPSYSGL SMVSGVKQGS GPAPTTHKGT PKTNRTNKPS TPTTATRKKK DLKNFRNVDS NLANLIMNEI VDNGTAVKFD DIAGQDLAKQ ALQEIVILPS LRPELFTGLR APARGLLLFG PPGNGKTMLA KAVAAESNAT FFNISAASLT SKYVGEGEKL VRALFAVARE LQPSIIFIDE VDSLLCERRE GEHDASRRLK TEFLIEFDGV QSAGDDRVLV MGATNRPQEL DEAVLRRFIK RVYVSLPNEE TRLLLLKNLL CKQGSPLTQK ELAQLARMTD GYSGSDLTAL AKDAALGPIR ELKPEQVKNM SASEMRNIRL SDFTESLKKI KRSVSPQTLE AYIRWNKDFG DTTV